Company Filing History:
2 out of 9 
1 out of 10 
1 out of 14 
Years Active: 2021-2022
Title: **The Innovative Contributions of Seohyun Ahn**
Introduction
Seohyun Ahn, based in Gyeonggi-do, South Korea, is an accomplished inventor with a focus on medicinal chemistry and therapeutic agents. With a portfolio of two patents, Ahn has made significant strides in the field of pharmaceutical innovations, particularly targeting receptor tyrosine kinases and inflammatory diseases.
Latest Patents
Ahn's latest patents include the development of 2-amino-benzimidazole derivatives, which serve as inhibitors for 5-lipoxygenase and/or prostaglandin E synthase. These compounds are aimed at treating various diseases, including inflammatory conditions, cancer, stroke, and Alzheimer's disease. The specific formulation consists of benzimidazole derivatives characterized by a complex structure that involves multiple reactive groups, enhancing their efficacy as therapeutic agents.
Another notable patent is centered on quinoline derivatives functioning as inhibitors of TAM receptor tyrosine kinases (RTKs), including Axl, Mer, and Tyro 3. These innovative compounds are tailored for the treatment of hyperproliferative disorders, such as cancers that can be immune-suppressive or resistant to conventional therapies, as well as addressing cancer metastasis.
Career Highlights
Throughout his professional journey, Seohyun Ahn has been associated with esteemed companies, including Qurient Co., Ltd. and Lead Discovery Center GmbH. His experience at these organizations highlights his commitment to advancing drug discovery and therapeutic development.
Collaborations
Ahn has collaborated with notable coworkers, including Kiyean Nam and Jaeseung Kim. These partnerships have undoubtedly contributed to his innovative work, facilitating the exchange of ideas and expertise in research and development initiatives.
Conclusion
Seohyun Ahn represents a dedicated inventor whose contributions to the field of pharmaceuticals are making an impactful difference in the treatment of severe diseases. His work underscores the importance of innovative solutions in addressing health challenges and improving patient outcomes.